Linclatamig

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 05:57:17 GMT 2025` Edited by `admin` on `Wed Apr 02 05:57:17 GMT 2025`
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type	IGG1\|KAPPA
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	4NHP5YXY4Z
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

H-gamma1 heavy chain anti-LY6G6D humanized, G1v84-1 VH E44, CH1 K86 (1-442) [VH E44 (Homo sapiens IGHV3-23*01 (77.6%) -(IGHD) -IGHJ2*01 (92.3%) R120>P (104), CDR-IMGT [8.8.5] (26-33.51-58.97-101)) (1-112) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1, CH1 K

Preferred Name

English

Linclatamig

Official Name

English

Immunoglobulin G1 [39-lysine,185-glutamic acid,299-glycine,368-serine,370-alanine,409-valine], anti-(human CD3 antigen ?-chain) (human-Mus musculus clone 38E4v1-MD1 ?1-chain) disulfide with [44-glutamic acid,138-lysine] human-Mus musculus clone 38E4v1-MD

Common Name

English

linclatamig [INN]

Common Name

English

immunoglobulin G1-kappa, anti-[Homo sapiens LY6G6D (lymphocyte antigen 6 family member G6D, G6D, LY6-D, MEGT1, NG25)] and anti-[Homo sapiens CD3E (CD3 epsilon, Leu-4)], humanized monoclonal antibody, bispecific

Common Name

English

Code System Code Type Description

SMS_ID

300000015180